Abridge

Abridge, founded in 2018 by Dr. Shiv Rao, is a Pittsburgh-based company focused on transforming clinical documentation through AI. Its mission is to enhance understanding in healthcare by improving the efficiency of clinical note-taking. The company’s platform uses AI to summarise patient-clinician conversations and fill out electronic health records (EHR) in real time, helping clinicians reduce the time spent on documentation and focus more on patient care. Abridge’s AI technology is integrated with health systems like John Hopkins Medicine and Mayo Clinic, streamlining workflows and increasing clinician satisfaction.

Abridge’s AI-powered platform is known for its enterprise-grade capabilities, offering real-time, structured clinical notes that integrate seamlessly into existing EHR systems. The platform’s “Linked Evidence” feature is unique as it maps AI-generated summaries to the original conversation source, ensuring accuracy and trust in the generated notes. This makes Abridge a leader in generative AI for healthcare.
 

In June 2024, Abridge raised $300 million in a Series E funding round, boosting its valuation to $5.3 billion. The company has expanded its customer base, partnering with major healthcare institutions like AltaMed Health Services and Sharp HealthCare to improve clinical documentation. Additionally, Abridge has been recognised in industry reports, including the "Best in KLAS" ranking for its ambient AI platform.
 

Abridge’s team includes clinicians, technologists, and researchers, committed to building AI tools that benefit both healthcare providers and patients. The company’s AI solutions aim to reduce clinician burnout by cutting down the time spent on documentation, enabling more meaningful doctor-patient interactions. Abridge continues to innovate, developing new features to further integrate AI into healthcare systems for improved patient outcomes and operational efficiency.

Abridge was founded in 2018 by Dr. Shiv Rao, a practicing cardiologist at UPMC, with the aim of alleviating clinician burnout by automating the documentation process. The company developed an AI-powered platform that records patient-clinician conversations, transcribes them, and generates structured clinical notes in real-time. This technology integrates seamlessly with existing electronic health record (EHR) systems, allowing clinicians to focus more on patient care and less on administrative tasks.
 

In 2024, Abridge secured $150 million in Series C funding, led by Lightspeed Venture Partners and Redpoint Ventures, bringing its valuation to approximately $850 million. This capital enabled the company to expand its AI capabilities and enhance its platform's features. Abridge's technology was adopted by several healthcare systems, including the University of Kansas Health System and Yale New Haven Health System, to improve clinical documentation processes.

The company's growth continued with a $250 million Series D funding round in early 2025, co-led by Elad Gil and IVP, with participation from Lightspeed Venture Partners, CVS Health Ventures, Redpoint Venture, and NVentures. This investment allowed Abridge to further develop its AI capabilities and expand its market reach. By this time, Abridge's technology was implemented in approximately 100 U.S. healthcare systems, including rural setups and children's hospitals.
 

In June 2025, Abridge raised $300 million in a Series E funding round led by Andreessen Horowitz (a16z) and Khosla Ventures, increasing its valuation to $5.3 billion. The company used this capital to scale its platform, expand its workforce, and develop new products, including software to help with medical billing. Abridge's technology was now used by more than 150 health systems across the U.S., supporting over 50 million medical conversations annually.
 

Abridge's platform continued to evolve, offering features such as real-time prior authorisation and inpatient order generation. The company also expanded its partnerships with major healthcare institutions, including Mayo Clinic, Johns Hopkins Medicine, and Duke Health, to implement its AI-powered clinical documentation tools across various specialties and care settings.
 

As of October 2025, Abridge is headquartered in San Francisco, California, with an office in Pittsburgh, Pennsylvania. The company employs approximately 330 people and is exploring acquisitions to accelerate its growth and enhance its AI capabilities. Abridge remains committed to transforming the healthcare experience by reducing clinician burnout and improving patient care through innovative AI solutions.

Abridge's mission is to empower clinicians by reducing the time spent on administrative tasks, allowing them to focus more on patient care. Through its AI-powered platform, Abridge transforms patient-clinician conversations into accurate and structured clinical notes in real-time. This helps reduce clinician burnout, improve efficiency, and enhance the quality of patient interactions. The company is committed to building AI solutions that are deeply integrated with existing healthcare systems, enabling smoother workflows and better healthcare outcomes for both clinicians and patients.

Abridge aims to transform healthcare by creating deeper understanding and more meaningful interactions between clinicians and patients. The company envisions a future where AI-powered tools reduce administrative burdens on healthcare professionals, enabling them to spend more time with patients. Abridge’s technology strives to enhance clinical documentation efficiency, improve the quality of care, and streamline the healthcare system. The company is dedicated to setting new standards for responsible AI deployment, ensuring its solutions are reliable, transparent, and trusted by healthcare providers across the world.

Abridge has been recognised as a leader in AI for healthcare, receiving accolades for its innovative approach to clinical documentation. In 2025, the company was named Best in KLAS for Ambient AI, showcasing its impact on the healthcare industry. Abridge has also been featured in TIME's Best Inventions, highlighting its role in transforming healthcare with AI. The company’s efforts have earned praise from major healthcare institutions and investors, making it one of the most influential AI startups in the healthcare sector. Additionally, Abridge was listed on Forbes AI 50 and the Business Insider 2024 AI Power List.

Abridge offers a range of products and services that aim to streamline the documentation process in healthcare, helping clinicians reduce administrative workload and improve patient care. These products leverage advanced artificial intelligence (AI) to transform the way healthcare professionals interact with technology, focusing on efficiency, accuracy, and real-time integration with existing systems.
 

1. Clinical Documentation Platform:
The core product of Abridge is its AI-powered clinical documentation platform. This platform records patient-clinician conversations and automatically generates structured clinical notes in real-time. These notes are integrated directly into Electronic Health Record (EHR) systems, such as Epic, reducing the need for clinicians to manually transcribe notes after each patient interaction. This feature helps doctors, nurses, and other healthcare professionals focus more on patient care instead of administrative tasks, contributing to a reduction in clinician burnout.
 

Abridge’s platform uses natural language processing (NLP) and machine learning to capture and summarise key details from medical conversations. It can accurately identify clinical problems, diagnoses, medications, and other relevant information discussed during patient visits. The AI is capable of adapting to different medical specialties and languages, making it suitable for diverse healthcare settings.
 

2. Linked Evidence:
One of the standout features of Abridge’s platform is its "Linked Evidence" technology. This unique capability links every AI-generated summary to the original conversation source, providing transparency and accountability. Clinicians can verify the AI’s output by referring to the exact moment in the conversation from which the note was derived. This functionality builds trust in the platform’s summaries and ensures that the clinical notes are accurate and reliable.
 

By mapping AI-generated content back to its source, Abridge ensures that clinicians have a clear understanding of the context, which is essential for providing high-quality care and making informed decisions. This makes the platform not only a time-saving tool but also a highly reliable source for medical documentation.
 

3. Real-Time Prior Authorization:
Abridge has developed a real-time prior authorisation feature, which is particularly useful in streamlining the process of securing insurance approval for medical procedures, prescriptions, and tests. Traditionally, prior authorisation can be a lengthy and manual process, often causing delays in patient care. Abridge’s AI platform integrates this step directly into the clinician’s workflow, allowing them to complete the necessary tasks during the patient consultation. This feature reduces delays, improves the efficiency of patient care, and ensures that insurance approval is secured promptly.
 

4. Inpatient Order Generation:
For clinicians working in hospitals, Abridge offers an inpatient order generation feature. This service allows clinicians to generate medical orders in real-time during patient consultations, streamlining the administrative aspect of hospital care. It reduces the cognitive load on clinicians, as they do not have to manually enter orders after the consultation. Instead, Abridge’s platform captures the necessary data during the conversation and automatically generates the appropriate orders, which can then be reviewed and approved by the clinician.

5. Multilingual Support:
Abridge’s platform is designed to support healthcare professionals working with diverse patient populations. The AI technology can transcribe and generate notes in multiple languages, making it accessible to clinicians working in multicultural environments. This feature is particularly important in regions with large populations of non-native speakers, ensuring that language barriers do not hinder the quality of patient care.
 

6. Customisable EHR Integration:
Abridge offers deep integration with existing EHR systems, including Epic and other widely-used platforms. This ensures that the AI-generated notes and data seamlessly flow into the clinician’s existing workflows. The platform is customisable, allowing healthcare institutions to adapt it to their specific needs, whether in terms of specialty-specific templates or compliance with local healthcare regulations.

7. Enterprise Security and Compliance:
Abridge prioritises security and compliance, particularly in the healthcare sector where patient data protection is critical. The platform meets HIPAA (Health Insurance Portability and Accountability Act) requirements, ensuring that all patient data is encrypted and securely stored. It also offers Single Sign-On (SSO) for easy user management and provides custom governance controls for enterprise clients.
 

8. Research and Development in AI for Healthcare:
In addition to its core products, Abridge is heavily invested in ongoing research and development (R&D) to improve its AI capabilities. The company works with leading experts in AI and healthcare to develop more accurate, context-aware tools for medical documentation. Their research extends to eliminating AI “hallucinations” (incorrect information generated by AI) and improving the overall reliability of the platform’s outputs.